← All indications
Dilatation, Pathologic
The condition of an anatomical structure's being dilated beyond normal dimensions.
Drugs by status
Phase 3 trials (3)
Phase 2 trials (1)
Other trials (6)
Organizations
Organization Involved with Phase 4 Indications (12)
- National Cancer Institute, Egypt
- Chulalongkorn University
- Federal University of Rio Grande do Sul
- Georgetown University
- Oregon Health and Science University
- Queen's University, Belfast
- Tel Aviv University
- University of California, San Diego
- University of California, San Francisco
- University of Naples Frederico II
- Society of Family Planning
- Society of Family Planning Research Fund
Organization Involved with Phase 3 Indications (17)
- Merck
- Avedro, Inc.
- Menarini Group
- Topcon Medical Systems, Inc.
- Price Vision Group
- American-European Congress of Ophthalmic Surgery
- Cornea and Laser Eye Institute
- Ohio State University
- Rush Eye Associates
- Stanford University
- University of Pavia
- Cornea Genetic Eye Institute
- american eye institute
- Cornea Eye Institute, Beverly Hills
- KhonKaen University
- Government of Spain
- Ocuphire Pharma, Inc.
Organization Involved with Phase 2 Indications (6)
Organization Involved with Phase 1 Indications (7)
Organization Involved with Other Experimental Indications (19)
- Planned Parenthood
- Federal University of Minas Gerais
- University of Washington
- Hillel Yaffe Medical Center
- Ibis Reproductive Health
- Imelda Hospital, Bonheiden
- Katholieke Universiteit Leuven
- Thomas Jefferson University
- University of Hawaii
- University of South Florida
- University of Arkansas
- University of Athens
- Columbia University
- University of Cape Town
- University of Ankara
- Catholic University of Sacred Heart, Rome
- Stellenbosch University
- Rouen Normandy University
- Kaiser Clinic and Hospital